Navigation Links
OHSU Cancer Institute researcher: radiation, immunotherapy gives greater effectiveness
Date:9/25/2008

PORTLAND, Ore. Oregon Health & Science University Cancer Institute researchers have found the right formula of radiation and immunotherapy for fighting lung cancer tumors in mice, which they hope will translate to better treatment in human lung cancers.

The study was presented today at the 50th annual American Society for Therapeutic Radiology and Oncology conference in Boston.

Principal investigator Marka Crittenden, M.D., Ph.D., and colleagues designed the study in order to look at the effects of stereotactic body radiation therapy (SBRT) on the immune system. This type of radiation is delivered in three large doses over several days. The extreme precision of this technology helps to spare normal, healthy tissue, more accurately targeting the cancerous tumor.

"We studied the consequences of SBRT radiation doses in preclinical tumors and found that there were fewer of the cells that turn off the immune system and more of the good 'killer' immune cells following these radiation doses," said Crittenden, OHSU Department of Radiation Medicine, OHSU School of Medicine.

Researchers then selected a form of immunotherapy that could boost the immune response while working with the immune response generated by the SBRT. Cancer immunotherapy works to boost the body's own immune system to attack tumor cells. They found that SBRT combined with immunotherapy was much more effective at clearing the tumor than either used alone.

"We hope to translate this to patient studies and develop therapies combining the potent tumor destruction of SBRT with the patient's own immune system to further improve the efficacy of radiation therapy for cancer," Crittenden said.

The presentation is titled: "Development of a Preclinical Model to Test Adjuvant Immunotherapy in Combination With SBRT."


'/>"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
Source:Eurekalert

Page: 1

Related medicine news :

1. Video: One A Day(R) and Ellen DeGeneres Team Up to Deliver a Message to Women About Breast Cancer Through The One A Day Womens Wake-Up Call Program
2. Breast Cancer Action Targets Yoplait in Think Before You Pink Campaign; Calls for Yogurt Without Artificial Hormones
3. Early Breast Cancer No More Likely to Return in Young Women
4. Chilis Grill & Bar(R) to Donate 100 Percent of All Profits on Monday, Sept. 29 to St. Jude Childrens Research Hospital as Part of Annual Create-A-Pepper to Fight Childhood Cancer Campaign
5. Cancer patients who receive neoadjuvant therapy followed by mastectomy may not need radiation
6. Age alone should not be used to determine whether to treat prostate cancer with hormones
7. Molecular imaging technology used in gastric cancer
8. Racial disparities decline for cancer in Missouri
9. OHSU Cancer Institute researchers study breathing during radiation
10. Open cancer surgery set to become a thing of the past
11. Ovarian and Endometrial Cancer Patients Experience Improved Outcomes When Treated First by a Gynecologic Oncologist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. 24, 2014 (HealthDay ... of youth" drug that can delay the effects of aging ... suggests. Seniors received a significant boost to their immune ... pathway linked to aging and immune function, researchers with the ... a version of the drug rapamycin, improved the seniors, immune ...
(Date:12/25/2014)... Aliso Viejo, California (PRWEB) December 25, 2014 ... the release of ProFire 5k. A fully customizable business ... X . , “Adding the ProFire 5k business tool, ... style” Said Christina Austin, CEO of Pixel Film Studios. ... the look and style to add professionalism to a ...
(Date:12/24/2014)... December 25, 2014 AlignLife of Wauwatosa ... to afford certain items. During the holiday season, AlignLife looks ... over 70 toys," says Dr. Sara Mahalko-Leonhardt, owner of AlignLife. ... such joy, knowing that we are able to give kids ... it not been for the generosity of our patients." , ...
(Date:12/24/2014)... a famous dress manufacturer and retailer, has announced its ... items are brand new; they are made by experienced designers. ... new range of high quality prom gowns. A lot of ... made according to the latest trends. For years, the supplier ... company is handpicked by skilled tailors. , In the comments ...
(Date:12/24/2014)... York (PRWEB) December 24, 2014 ... ) that allege the blood thinner caused life-threatening ... outlined a leadership structure for the proceeding, Bernstein ... December 17th, the Court plans to select lawyers ... and also plans on appointing a Plaintiffs’ Steering ...
Breaking Medicine News(10 mins):Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3
... Hematopoietic stem cell transplantation (HSCT) and associated immunosuppression ... infections (IFIs). IFIs are a significant cause of morbidity ... epidemiology of IFIs have led to an increased frequency ... are linked to poor outcomes in patients. It is ...
... National Awareness Campaign to Combat Breast Cancer has ... Cancer Awareness month. The campaign is led by Princess Hessah bint ... and wife of the Custodian of the Two Holy ... Abdullah bin Abdulaziz. It officially launched on October 10. , ...
... - A study published in the October issue of ... tumor-suppressor protein p53, coupled with elimination of the DNA-maintenance ... a result, tissues deteriorate rapidly, which is generally fatal ... evidence for the use of inhibitors of ATR in ...
... to prevent fever at shot time could be counterproductive, researchers ... a vaccination is a normal and essential part of ... known in the U.S. as Tylenol -- after a shot ... some vaccines, transient fever means that a child,s immune system ...
... ... Meeting , ... (Vocus) October 16, 2009 -- An injured Iraqi citizen, a port wine stain patient, ... Patients of Courage: Triumph Over Adversity awards by the American Society of Plastic Surgeons (ASPS) ...
... , News facts: , October, ... individuals with breast cancer, however the experiences of those living ... the disease, is rarely discussed., MBC, also known as ... cancer has spread beyond the breast to other parts of ...
Cached Medicine News:Health News:Invasive Fungal Infections in HSCT Recipients: Improving Outcomes Through Prevention and Treatment 2Health News:Loss of tumor-suppressor and DNA-maintenance proteins causes tissue demise 2Health News:Acetaminophen May Weaken Effectiveness of Kids' Vaccines 2Health News:Reconstructive Plastic Surgery Patients Honored for Giving Back 2Health News:Reconstructive Plastic Surgery Patients Honored for Giving Back 3Health News:Reconstructive Plastic Surgery Patients Honored for Giving Back 4Health News:Video: Cities and States Around the U.S. Recognize October 13 as Metastatic Breast Cancer Awareness Day 2Health News:Video: Cities and States Around the U.S. Recognize October 13 as Metastatic Breast Cancer Awareness Day 3
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... decision support to healthcare providers for behavioral health ... has secured $30 million in equity financing from ... C. Drosos , President and Chief Executive Officer. ... adoption and development of Assurex Health,s GeneSight ...
(Date:12/24/2014)... DUBLIN and RALEIGH, N.C. ... subsidiary of Endo International plc (NASDAQ: ENDP ... BDSI ) announced today that they have ... Buccal Film to the U.S. Food and Drug Administration ... the management of pain severe enough to require daily, ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... "US Self-monitoring Blood Glucose Market" report to ... This market insight focuses on the developments ... the United States . Reimbursement analysis and the ... analyses for more than 73 SMBG meters have been ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5US Self-monitoring Blood Glucose Market 2
...   Syndax Pharmaceuticals, Inc ., a clinical-stage epigenetics oncology ... 2 clinical trials with entinostat in combination and as ... conferences.  San Antonio Breast Cancer ... randomized, double-blind, placebo-controlled, phase 2 study of exemestane with ...
...  Henry Schein, Inc., (NASDAQ: HSIC ), the ... office-based practitioners, announced today that Stanley Bergman, Chairman and ... the Company,s Executive Vice President and Chief Financial Officer, ... on December 6.  The conference is being held at ...
Cached Medicine Technology:Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences 2Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences 3Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences 4Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences 5Henry Schein to Present at the NASDAQ OMX 27th Investor Program 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: